A Comprehensive Review on DNA Gyrase Inhibitors

Infect Disord Drug Targets. 2020;20(6):765-777. doi: 10.2174/1871526520666200102110235.

Abstract

The newly emerging infectious organisms, the global crisis in antibiotic resistance, and the threat of bioterrorism create an urgent need to discover novel antimicrobial agents. In order to develop novel antimicrobial agents, the mechanism of infectious disease must be better understood. DNA Gyrase is a bacterial enzyme that plays an important role in the replication of DNA and transcription process. It is not present in higher eukaryotes making it a perfect target for developing new antibacterial agents. This review describes the role of DNA gyrase inhibitors in preventing various diseases. In this review, we outline the synthesis and pharmacological action of various novel DNA gyrase inhibitors. DNA gyrase inhibitors were used to treat tuberculosis, bacterial, fungal infections and malaria. DNA gyrase inhibitors mainly act by preventing the supercoiling of DNA strands..

Keywords: DNA gyrase inhibitors; antibacterial; anticancer; antimalarial; docking; fungal infections.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteria / drug effects
  • DNA Gyrase
  • Drug Resistance, Microbial / drug effects
  • Humans
  • Topoisomerase II Inhibitors / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Topoisomerase II Inhibitors
  • DNA Gyrase